Recently, Zhang et al. have reported that miR-302b inhibits cancer-related inflammation by regulating ERBB4, IRF2, and CXCR4 post-transcriptionally, while downregulation of these genes leads to decreased cytokine production, suggesting that ERBB4 plays a role in inflammation [41]. Here, IRF2 is linked to cancer.